Bajaj Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
305.55
1.1 (0.36%)
BSENSE

May 22

BSE+NSE Vol: 80.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -0.91% vs 15.36% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -304.38% vs 137.37% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 93.02% vs -26.75% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -8.39% vs 1.16% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Bajaj Healthcare With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
153.06
0
153.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
153.06
0
153.06
Raw Material Cost
92.10
0
92.10
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-10.59
0
-10.59
Employee Cost
16.30
0
16.30
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
32.57
0.00
32.57
Total Expenditure (Excl Depreciation)
130.38
0
130.38
Operating Profit (PBDIT) excl Other Income
22.68
0.00
22.68
Other Income
2.96
0
2.96
Operating Profit (PBDIT)
25.64
0
25.64
Interest
5.57
0
5.57
Exceptional Items
-36.69
0
-36.69
Gross Profit (PBDT)
-13.18
0
-13.18
Depreciation
7.63
0
7.63
Profit Before Tax
-20.81
0
-20.81
Tax
-1.40
0
-1.40
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-19.41
0
-19.41
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
-3.44
0
-3.44
Net Profit
-22.85
0
-22.85
Equity Capital
16.83
0
16.83
Face Value
5.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
-6.79
0
-6.79
Diluted Earnings per share
-7.15
0
-7.15
Operating Profit Margin (Excl OI)
14.82%
0%
0.00
14.82%
Gross Profit Margin
-8.61%
0%
0.00
-8.61%
PAT Margin
-12.68%
0%
0.00
-12.68%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 153.06 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -5.06% vs 9.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -0.91% vs 15.36% in Mar 2025

Quarterly - Standalone Net Profit
Standalone Net Profit -22.85 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -245.82% vs 41.04% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -304.38% vs 137.37% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.68 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -26.08% vs 13.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 93.02% vs -26.75% in Mar 2025

Quarterly - Interest
Interest 5.57 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -5.27% vs 5.76% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -8.39% vs 1.16% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.82%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025